• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Review on the multifactorial aspects of bioincompatibility in CPB.

作者信息

Daniel S

机构信息

COBE Cardiovascular, Rungis, France.

出版信息

Perfusion. 1996 May;11(3):246-55. doi: 10.1177/026765919601100310.

DOI:10.1177/026765919601100310
PMID:8817633
Abstract

Over the last few years, a great emphasis has been placed on the bioincompatibility of foreign, nonphysiological materials used during CPB. It is only recently that bioincompatibility has objectively been recognized to be multifactorial, with the dominant implicated sources being cardiotomy blood suction, shear stresses or flow dynamics and, to a lesser degree, the blood/artificial surface interactions, the heparin/protamine complex and the various forms of emboli or debris. In summary, in CPB, the reduction of postoperative complications, such as whole body inflammatory reactions, bleeding and organ dysfunctions, can only be impacted if the primary, dominant sources of bioincompatibility are reduced or eliminated.

摘要

相似文献

1
Review on the multifactorial aspects of bioincompatibility in CPB.
Perfusion. 1996 May;11(3):246-55. doi: 10.1177/026765919601100310.
2
Systemic inflammatory response and the splanchnic bed in cardiopulmonary bypass.
Perfusion. 1996 May;11(3):200-12. doi: 10.1177/026765919601100305.
3
Nafamostat mesilate reduces blood-foreign surface reactions similar to biocompatible materials.
Ann Thorac Surg. 1996 Nov;62(5):1404-11. doi: 10.1016/0003-4975(96)00634-0.
4
The early inflammatory response in a mini-cardiopulmonary bypass system: a prospective randomized study.小型体外循环系统中的早期炎症反应:一项前瞻性随机研究。
Innovations (Phila). 2012 Jan-Feb;7(1):23-32. doi: 10.1097/IMI.0b013e3182552ade.
5
The influence of biomaterials on inflammatory responses to cardiopulmonary bypass.生物材料对体外循环炎症反应的影响。
Perfusion. 1996 May;11(3):220-8. doi: 10.1177/026765919601100307.
6
Biocompatibility: complement as mediator of tissue damage and as indicator of incompatibility.生物相容性:补体作为组织损伤的介质和不相容性的指标。
Exp Clin Immunogenet. 1997;14(1):24-9.
7
Biomaterial development for cardiopulmonary bypass.用于体外循环的生物材料研发
Perfusion. 2001 Sep;16(5):381-90. doi: 10.1177/026765910101600508.
8
Biocompatibility reflected by haemostasis variables during cardiopulmonary bypass using heparin-coated circuits.使用肝素涂层回路进行体外循环期间,止血变量所反映的生物相容性。
Thorac Cardiovasc Surg. 1997 Aug;45(4):163-7. doi: 10.1055/s-2007-1013716.
9
Pericardial suction blood separation attenuates inflammatory response and hemolysis after cardiopulmonary bypass.心包腔吸引血液分离可减轻体外循环后的炎症反应和溶血。
Scand Cardiovasc J. 2006 Aug;40(4):219-23. doi: 10.1080/14017430600628201.
10
The inflammatory response to cardiopulmonary bypass: a therapeutic overview.体外循环的炎症反应:治疗概述。
Perfusion. 2004;19 Suppl 1:S5-12. doi: 10.1191/0267659104pf717oa.

引用本文的文献

1
Association between cardioplegia and postoperative atrial fibrillation in coronary surgery.心脏停搏液与冠状动脉手术后心房颤动的关系。
Int J Cardiol. 2021 Feb 1;324:38-43. doi: 10.1016/j.ijcard.2020.09.065. Epub 2020 Oct 4.
2
Mechanisms of oxidative stress and myocardial protection during open-heart surgery.心脏直视手术期间氧化应激与心肌保护的机制
Ann Card Anaesth. 2015 Oct-Dec;18(4):555-64. doi: 10.4103/0971-9784.166465.